Sedation for symptom control in Japan: The importance of intermittent use and communication with family members

Journal of Pain and Symptom Management

Volumn 12, Issue 1, 1996, Pages 32-38

  Morita, Tatsuya ^a   Inoue, Satoshi ^a   Chihara, Satoshi ^a  

^a Seirei Mikatabara Hospital   (Japan)

Author keywords

informed consent; midazolam; palliative care; refractory symptom; Sedation; terminally ill

Indexed keywords

BARBITURIC ACID DERIVATIVE; BROMAZEPAM; CHLORPROMAZINE; DIAZEPAM; HALOPERIDOL; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; SCOPOLAMINE BROMIDE; STEROID;

ADULT; AGED; AGITATION; ARTICLE; CANCER PATIENT; DELIRIUM; DYSPNEA; FEMALE; HOSPICE; HUMAN; INTERPERSONAL COMMUNICATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALAISE; MALE; MORTALITY; NAUSEA; PAIN; PALLIATIVE THERAPY; PHYSICIAN ATTITUDE; RESPIRATION DEPRESSION; SEDATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030005429     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(96)00046-2     Document Type: Article

References (14)

1. Ventafridda V, Ripamonti C, De Connno F, et al. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990;6:7-11.
2. Fainsinger R, Miller MJ, Bruera E, et al. Symptom control during the last week of life on palliative care unit. J Palliat Care 1991;7:5-11.
3. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990;6:7-15.
4. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-38.
5. Barkwell DP. Ascribed meaning: a critical factor in coping and pain attenuation in patients with cancer-related pain. J Palliat Care 1991;7:5-14.
6. Seale C, Addington-Hall J. Euthanasia: why people want to die earlier. Soc Sci Med 1994;39: 647-654.
7. van der Maas PJ, van Delden JJM, Pijnenborg L, et al. Euthanasia and other medical decisions concerning the end of life. Lancet 1991;338:669-674.
8. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage 1990;5:83-93.
9. McKegney FP, Bailey LR, Yates JW. Prediction and management of pain in patients with advanced cancer. Gen Hosp Psychiatry 1981;3:95-101.
10. Beauchamp TL, Childress JF. The principle of nonmaleficience. In: Doyle D, Hanks GWC, Mac-Donald N, eds. Principles of biomedical ethics, 3rd ed. New York: Oxford University Press, 1989:127-134.
11. Bruera E, Miller L, McCallion L, et al. Cognitive failure in patients with terminal cancer: prospective study. J Pain Symptom Manage 1992;7:192-195.
12. McNamara P, Minton M, Twycross RG. Use of midazolam in palliative care. Palliat Med 1991;5: 244-249.
13. Greene WR, Davis WH. Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. South Med J 1991;84:332-337.
14. Truog RD, Berde CB, Mitchell C, et al. Barbiturates in the care of the terminally ill. N Engl J Med 1992;327:1678-1682.